Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2162-3619
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting ; volume:11 ; number:1 ; day:24 ; month:9 ; year:2022 ; pages:1-17 ; date:12.2022
Experimental hematology & oncology ; 11, Heft 1 (24.9.2022), 1-17, 12.2022
- Urheber
-
Wang, Ji-nuo
Gu, Tianning
Hu, Yongxian
Huang, He
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40164-022-00316-8
- URN
-
urn:nbn:de:101:1-2022121221024926683807
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Ji-nuo
- Gu, Tianning
- Hu, Yongxian
- Huang, He
- SpringerLink (Online service)
Ähnliche Objekte (12)
Special issue: CAR‐T cell therapy for hematological malignancies
The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia
Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting
Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
An in vivo study of the best light emitting diode (LED) systems for cut chrysanthemums
Outcome of Pneumocystis Jirovecii pneumonia (PcP) in post-CAR-T patients with hematological malignancies
The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation
COVID-19 in Hematologic Malignancies: Big Challenges
How do commodity futures respond to macroeconomic news?
Special issue: CAR‐T cell therapy for hematological malignancies
The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia
Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting
Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
An in vivo study of the best light emitting diode (LED) systems for cut chrysanthemums
Outcome of Pneumocystis Jirovecii pneumonia (PcP) in post-CAR-T patients with hematological malignancies
The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation
COVID-19 in Hematologic Malignancies: Big Challenges
How do commodity futures respond to macroeconomic news?
Special issue: CAR‐T cell therapy for hematological malignancies
The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia
Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting
Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
An in vivo study of the best light emitting diode (LED) systems for cut chrysanthemums
Outcome of Pneumocystis Jirovecii pneumonia (PcP) in post-CAR-T patients with hematological malignancies
The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation
COVID-19 in Hematologic Malignancies: Big Challenges